B G Macik - JoVE Visualize

Showing results (11-20 of 20) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 20 results.

Archives of Pathology & Laboratory Medicine|February 1, 1988

The use of high-dose intravenous gamma-globulin in acquired von Willebrand syndromeB G Macik, D A Gabriel, G C White, et al.

Investigational New Drugs|January 1, 1983

In vitro cellular characteristics and survival responses of human astrocytoma clones to chloroethyl-nitrosoureas and dianhydrogalactitolN H Rubin, C Casartelli, B G Macik, et al.

Thrombosis Research|December 1, 1989

Mechanism by which recombinant factor VIIa shortens the aPTT: activation of factor X in the absence of tissue factorD S Telgt, B G Macik, D M McCord, et al.

Prenatal Diagnosis|September 1, 1994

Fetal renal vein thrombosis, hydrops fetalis, and maternal lupus anticoagulant. A case reportM L Hage, R Liu, D G Marcheschi, et al.

Radiology|August 1, 1994

Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findingsJ M Provenzale, E R Heinz, T L Ortel, et al.

Clinical Chemistry|October 1, 1994

Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2C S Greenberg, M J Hursting, B G Macik, et al.

Cancer Research|April 1, 1983

Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomachS C Barranco, C M Townsend, C Casartelli, et al.

American Journal of Hematology|February 1, 1994

Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosisT L Ortel, L A Charles, F G Keller, et al.

Clinical Pharmacology and Therapeutics|June 1, 1994

Pharmacokinetics and pharmacodynamics of recombinant factor VIIaC M Lindley, W T Sawyer, B G Macik, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1993

Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a phase I studyB G Macik, C M Lindley, J Lusher, et al.

Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 20 results.

Archives of Pathology & Laboratory Medicine|February 1, 1988

The use of high-dose intravenous gamma-globulin in acquired von Willebrand syndromeB G Macik, D A Gabriel, G C White, et al.

Investigational New Drugs|January 1, 1983

In vitro cellular characteristics and survival responses of human astrocytoma clones to chloroethyl-nitrosoureas and dianhydrogalactitolN H Rubin, C Casartelli, B G Macik, et al.

Thrombosis Research|December 1, 1989

Mechanism by which recombinant factor VIIa shortens the aPTT: activation of factor X in the absence of tissue factorD S Telgt, B G Macik, D M McCord, et al.

Prenatal Diagnosis|September 1, 1994

Fetal renal vein thrombosis, hydrops fetalis, and maternal lupus anticoagulant. A case reportM L Hage, R Liu, D G Marcheschi, et al.

Radiology|August 1, 1994

Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findingsJ M Provenzale, E R Heinz, T L Ortel, et al.

Clinical Chemistry|October 1, 1994

Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2C S Greenberg, M J Hursting, B G Macik, et al.

Cancer Research|April 1, 1983

Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomachS C Barranco, C M Townsend, C Casartelli, et al.

American Journal of Hematology|February 1, 1994

Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosisT L Ortel, L A Charles, F G Keller, et al.

Clinical Pharmacology and Therapeutics|June 1, 1994

Pharmacokinetics and pharmacodynamics of recombinant factor VIIaC M Lindley, W T Sawyer, B G Macik, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1993

Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a phase I studyB G Macik, C M Lindley, J Lusher, et al.

Pageof 2